State of Oral Mucosa as an Additional Symptom in the Course of Primary Amyloidosis and Multiple Myeloma Disease
Multiple myeloma (myeloma multiplex (MM)) is a malignant non-Hodgkin’s lymphoma derived from B cell. Its essence is a malignant clone of plasma cells synthesizing growth of monoclonal immunoglobulin, which infiltrate the bone marrow, destroy the bone structure, and prevent the proper production of b...
Main Authors: | Maciej R. Czerniuk, Artur Jurczyszyn, Grzegorz Charlinski |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2014/293063 |
Similar Items
-
Next-generation immunomodulatory drugs in multiple myeloma
by: Anna Suska, et al.
Published: (2019-12-01) -
Rapid Progress in the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma
by: Grzegorz Charliński, et al.
Published: (2021-09-01) -
Myeloma associated primary systemic amyloidosis
by: Jong, T., et al.
Published: (2016) -
Primary systemic amyloidosis with multiple myeloma presenting with unusual pancreatitis and colitis
by: Chih-Pin Chen
Published: (2015-09-01) -
Epidemiology and etiopathogenesis of multiple myeloma and monoclonal gammapathy of undetermined significance
by: Anna Suska, et al.
Published: (2018-11-01)